IL17A and autoimmune hepatitis: More recently, studies have reported that CD39posTregs not only are decreased in frequency but also exhibit limited adenosine triphosphate/adenosine diphosphate hydrolysis activity in AIH patients, which in turn fail to suppress the overactive IL-17 pathway by effector CD4+ T cells [55].